These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 4028625)
1. Influence of transdermal scopolamine on motion sickness during 7 days' exposure to heavy seas. van Marion WF; Bongaerts MC; Christiaanse JC; Hofkamp HG; van Ouwerkerk W Clin Pharmacol Ther; 1985 Sep; 38(3):301-5. PubMed ID: 4028625 [TBL] [Abstract][Full Text] [Related]
2. [Transdermal therapeutic system of scopolamine (TTS-S) in the prevention of sea sickness and its mechanism of action]. Wang E Zhonghua Er Bi Yan Hou Ke Za Zhi; 1990 Oct; 25(5):299-302, 319. PubMed ID: 2076342 [TBL] [Abstract][Full Text] [Related]
3. Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications. Nachum Z; Shupak A; Gordon CR Clin Pharmacokinet; 2006; 45(6):543-66. PubMed ID: 16719539 [TBL] [Abstract][Full Text] [Related]
4. Effect of transdermally administered scopolamine in preventing motion sickness. McCauley ME; Royal JW; Shaw JE; Schmitt LG Aviat Space Environ Med; 1979 Nov; 50(11):1108-11. PubMed ID: 393242 [TBL] [Abstract][Full Text] [Related]
6. [Prevention of motion sickness with a transdermal therapeutic system containing scopolamine. A randomized, comparative double-blind study in the German Federal Navy]. Becker G; Goossens H; Seemann K; Souchon F; Weitz T Dtsch Med Wochenschr; 1984 Dec; 109(49):1881-5. PubMed ID: 6499689 [TBL] [Abstract][Full Text] [Related]
7. [Transdermal scopolamine (TTS-scopolamine) for the prevention of postoperative nausea and vomiting]. Tolksdorf W; Meisel R; Müller P; Bender HJ Anaesthesist; 1985 Dec; 34(12):656-62. PubMed ID: 4096357 [TBL] [Abstract][Full Text] [Related]
8. Drug treatment of motion sickness: scopolamine alone and combined with ephedrine in real and simulated situations. Tokola O; Laitinen LA; Aho J; Gothoni G; Vapaatalo H Aviat Space Environ Med; 1984 Jul; 55(7):636-41. PubMed ID: 6466260 [TBL] [Abstract][Full Text] [Related]
9. Transdermally administered scopolamine vs. dimenhydrinate. I. Effect on nausea and vertigo in experimentally induced motion sickness. Pyykkö I; Schalén L; Jäntti V Acta Otolaryngol; 1985; 99(5-6):588-96. PubMed ID: 4024909 [TBL] [Abstract][Full Text] [Related]
10. Safety of double-dose transdermal scopolamine. Bar R; Gil A; Tal D Pharmacotherapy; 2009 Sep; 29(9):1082-8. PubMed ID: 19698013 [TBL] [Abstract][Full Text] [Related]
11. The effects of TTS-scopolamine, dimenhydrinate, lidocaine, and tocainide on motion sickness, vertigo, and nystagmus. Pyykkö I; Padoan S; Schalén L; Lyttkens L; Magnusson M; Henriksson NG Aviat Space Environ Med; 1985 Aug; 56(8):777-82. PubMed ID: 3929760 [TBL] [Abstract][Full Text] [Related]
12. Treatment of motion sickness in parabolic flight with buccal scopolamine. Norfleet WT; Degioanni JJ; Calkins DS; Reschke MF; Bungo MW; Kutyna FA; Homick JL Aviat Space Environ Med; 1992 Jan; 63(1):46-51. PubMed ID: 1550533 [TBL] [Abstract][Full Text] [Related]
13. Transdermal scopolamine in the prevention of motion sickness at sea. Price NM; Schmitt LG; McGuire J; Shaw JE; Trobough G Clin Pharmacol Ther; 1981 Mar; 29(3):414-9. PubMed ID: 7009021 [TBL] [Abstract][Full Text] [Related]
14. Transdermal hyoscine and postoperative nausea and vomiting. Uppington J; Dunnet J; Blogg CE Anaesthesia; 1986 Jan; 41(1):16-20. PubMed ID: 3946771 [TBL] [Abstract][Full Text] [Related]
16. Preoperative transdermal hyoscine for the prevention of postoperative nausea and vomiting. Wilkinson AR; Frampton CM; Glover PW; Davis FM Anaesth Intensive Care; 1989 Aug; 17(3):285-9. PubMed ID: 2774147 [TBL] [Abstract][Full Text] [Related]
17. [Effects and side effects of transdermal scopolamine for premedication in general anesthesia in elderly patients]. Tolksdorf W; Baumann S; Heine C; Hettenbach A Anasth Intensivther Notfallmed; 1986 Dec; 21(6):301-6. PubMed ID: 3544938 [TBL] [Abstract][Full Text] [Related]
18. Scopolamine bioavailability in combined oral and transdermal delivery. Nachum Z; Shahal B; Shupak A; Spitzer O; Gonen A; Beiran I; Lavon H; Eynan M; Dachir S; Levy A J Pharmacol Exp Ther; 2001 Jan; 296(1):121-3. PubMed ID: 11123371 [TBL] [Abstract][Full Text] [Related]
19. Transdermal scopolamine reduces nausea and vomiting after outpatient laparoscopy. Bailey PL; Streisand JB; Pace NL; Bubbers SJ; East KA; Mulder S; Stanley TH Anesthesiology; 1990 Jun; 72(6):977-80. PubMed ID: 2140929 [TBL] [Abstract][Full Text] [Related]
20. Transdermal scopolamine in the prevention of motion sickness: evaluation of the time course of efficacy. Homick JL; Kohl RL; Reschke MF; Degioanni J; Cintron-Trevino NM Aviat Space Environ Med; 1983 Nov; 54(11):994-1000. PubMed ID: 6651736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]